Pharmacy News

The True Promise of Quality by Design: Risks & Rewards

Add bookmark

In this exclusive interview Jesús Zurdo, Head of Innovation, Biopharma Development, Lonza Biologics, speaks to Andrea Charles from Pharma IQ about improving the developability of biopharmaceuticals, the advantages of implementing early risk assessment and enhancing manufacture through Quality By Design (QbD). Zurdo also shares his views on the future and true promise of QbD.

Pharma IQ: What sort of current trends have you witnessed, with regards to improving the developability of bio…

To continue reading this story get free access

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Ad Block Detected

Welcome to Mediexpose, Please support our journalism by allowing ads. With support from readers like you, we can continue to deliver the best. You can support us free by simply allowing ads.